Alan J. Tuchman - 31 Dec 2025 Form 5 Insider Report for TAO Synergies Inc. (TAOX)

Role: Chief Medical Officer, Director
Signature: /s/ Robert Weinstein, Attorney-in-fact
Issuer symbol: TAOX
Transactions as of: 31 Dec 2025
Net transactions value: $0
Form type: 5
Filing time: 05 Feb 2026, 17:14:08 UTC
Previous filing: 02 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
TUCHMAN ALAN J	Chief Medical Officer, Director	C/O TAO SYNERGIES INC., 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK	/s/ Robert Weinstein, Attorney-in-fact	05 Feb 2026	0001417631

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TAOX	Employee Stock Option (right to buy)	Award	$0	+2,000		$0.000000	2,000	06 Aug 2025	Common Stock	2,000	$10.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Alan J. Tuchman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025.